Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?

被引:15
|
作者
Gauchan, Dron [1 ,2 ,3 ]
Joshi, Nitin [1 ,2 ,3 ]
Gill, Amandeep Singh [1 ,2 ,3 ]
Patel, Vishal [1 ,5 ]
DeBari, Vincent A. [4 ]
Guron, Gunwant [2 ,3 ]
Maroules, Michael [1 ,3 ]
机构
[1] St Josephs Reg Med Ctr, Dept Med, Div Hematol, Paterson, NJ 07503 USA
[2] St Michaels Hosp, Dept Hematol & Oncol, Newark, NJ USA
[3] Seton Hall Univ, Sch Hlth & Med Sci, Dept Hematol & Oncol, S Orange, NJ 07079 USA
[4] Seton Hall Univ, Sch Hlth & Med Sci, Dept Internal Med, S Orange, NJ 07079 USA
[5] St Georges Univ, Sch Med, Dept Internal Med, Grenada, St Kitts & Nevi
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2012年 / 12卷 / 04期
关键词
Cobalamin; Methylmalonic acid; Myeloproliferative disorders; Vitamin B-12; DIAGNOSIS; COBALAMIN; NEOPLASMS; BLOOD; B12;
D O I
10.1016/j.clml.2012.01.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Elevation of the methylmalonic acid level is a sensitive marker of vitamin B-12 deficiency. Our cross-sectional observational study of 33 patients with myeloproliferative disorders found that 9 patients, 27.27% had occult deficiency despite having normal to elevated serum vitamin B-12 levels. Early detection of vitamin B-12 deficiency by using the methylmalonic acid measurement may prevent significant neurologic and hematologic complications in patients with myeloproliferative disorders. In patients with myeloproliferative disorders, normal to high serum vitamin B-12 concentrations have often been reported. The primary objective of this study was to determine whether normal or elevated serum vitamin B-12 levels in myeloproliferative disorders might actually mask the true underlying vitamin B-12 deficiency in some patients. Thirty-three patients (12 men, 21 women; mean age, 70.55 years [range, 37-90 years]) with polycythemia vera (n = 13), essential thrombocythemia (n = 12), chronic myelogenous leukemia (n = 5), and idiopathic myelofibrosis (IMF) (n = 3) were accrued over a period of 1 year, from March 2009 to February 2010. From all of the subjects, serum vitamin B-12 level, methylmalonic acid level, a basic complete blood cell count panel, and liver and renal function tests were obtained. Normal to elevated serum vitamin B-12 levels were recorded in all the patients. However, elevated serum nnethylmalonic acid levels were found in 9(27.27%) patients, with a prevalence of 2 patients with polycythemia vera, 23% in polycythemia vera, 4 patients with essential thrombocythemia, 33.3% in essential thrombocythemia, 1 patient with chronic myelogenous leukemia, 20% in chronic myelogenous leukemia, and 2 patients with idiopathic myelofibrosis, 66.7% in IMF. Our data suggest that 27.27% of the total enrolled patients had occult vitamin B-12 deficiency despite normal to elevated vitamin B-12 levels on regular serum vitamin B-12 testing.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 50 条
  • [1] Elevated Serum Vitamin B12 Levels and Functional Vitamin B12 Deficiency among Patients with Myeloproliferative Neoplasms
    Harini, Murugesan
    Vinod, Kolar Vishwanath
    Adole, Prashant S.
    Dubashi, Biswajit
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [2] Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
    Vidal-Alaball, J
    Butler, CC
    Cannings-John, R
    Goringe, A
    Hood, K
    McCaddon, A
    McDowell, I
    Papaioannou, A
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03):
  • [3] Oral vitamin B12 versus intramuscular vitamin B12, for vitamin B12 deficiency
    Wang, Haiyan
    Li, Linyi
    Qin, Ling Ling
    Song, Yanan
    Vidal-Alaball, Josep
    Liu, Tong Hua
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [4] Diagnosis of Vitamin B12 Deficiency in Patients With Myeloproliferative Disorders
    Cinemre, Hakan
    Cinemre, Behice F. Serinkan
    Cekdemir, Demet
    Aydemir, Birsen
    Tamer, Ali
    Yazar, Hayrullah
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (04) : 636 - 640
  • [5] VITAMIN B12 BINDING CAPACITY OF SERUM IN B12 DEFICIENCY
    HELLER, P
    YAKULIS, V
    EPSTEIN, R
    HENDERSON, W
    CUNNINGHAM, B
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1964, 115 (02): : 342 - &
  • [6] VITAMIN B12 BINDING CAPACITY OF SERUM B12 DEFICIENCY
    HELLER, P
    YAKULIS, V
    CUNNINGHAM, B
    EPSTEIN, R
    HENDERSON, W
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1963, 62 (05): : 882 - &
  • [7] Oral vitamin B12 therapy in vitamin B12 deficiency
    Roth, M
    Orija, I
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (05): : 358 - 358
  • [8] High serum total vitamin B12 may mask biologically active B12 deficiency
    Lorde, Nathan
    Parkes, Jayne
    Sensi, Harminder
    Valentine, Ross
    Baker, Morven
    Ford, Clare
    Kalaria, Tejas
    Gama, Rousseau
    ANNALS OF CLINICAL BIOCHEMISTRY, 2024, 61 (03) : 233 - 234
  • [9] Oral vitamin B12 for B12 deficiency
    Cobcroft, R
    Cobcroft, S
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (09) : 451 - 451
  • [10] USEFULNESS OF SERUM HOLOTRANSCOBALAMIN II AND/OR VITAMIN B12 IN DIAGNOSIS OF VITAMIN B12 DEFICIENCY
    Haschke-Becher, E.
    Linnebank, M.
    Fowler, B.
    Kainz, A.
    Aigner, I.
    Niedetzky, P.
    Stanger, O.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S821 - S821